Terrie Curran
Chief Executive Officer at PHATHOM PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frank Karbe | M | 55 | 8 years | |
| David Socks | M | 49 | 6 years | |
| James Topper | M | 62 | 6 years | |
| Bhaskar Chaudhuri | M | 69 | 8 years | |
| Patrick Heron | M | 53 | 8 years | |
| David Elkins | M | 55 | 6 years | |
| Kathleen Sebelius | F | 75 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 6 years |
| Mark Guinan | M | 62 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 6 years |
| Eric Venker | M | 37 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 7 years |
| Todd Watanabe | M | 55 | 8 years | |
| Michael Cola | M | 64 | 5 years | |
| Asit Parikh | M | 52 | 5 years | |
| Sue-Jean Lin | F | 65 | 3 years | |
| Heidi Fields | F | 69 | 5 years | |
| Chirfi Guindo | M | 58 | 13 years | |
| David C. Marek | M | 59 | 3 years | |
| Mark Stenhouse | M | 57 | 4 years | |
| Matthew Gline | M | 40 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 8 years |
| Azmi Nabulsi | M | 64 | 6 years | |
| Masaru Matsuda | M | 53 | 2 years | |
| Jay Ramsinghani | M | - | 4 years | |
| Neha Krishnamohan | F | 37 | 2 years | |
| Dalton Smart | M | 58 | 15 years | |
| Lene Skole-Sørensen | F | 65 | 9 years | |
| Howard Welgus | M | 72 | 8 years | |
| Halley Gilbert | F | 54 | 4 years | |
| Keith Leonard | M | 62 | 3 years | |
| Jeremy Levin | M | 70 | 7 years | |
| Keith Manchester | M | 55 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 10 years |
| Adele Gulfo | F | 61 | 5 years | |
| Molly Henderson | F | 54 | 2 years | |
| Ayisha Jeter | F | - | 4 years | |
| Frank Torti | M | 45 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 6 years |
| Lars Erik Holmqvist | M | 64 | 9 years | |
| Atul Pande | M | 69 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Zachary Carpenter | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
| Clarence Machado | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Allan Gabor | M | - | 11 years | |
| Richard Pulik | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 years |
| Nikhil Kehtarpal | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
| George Bickerstaff | M | 68 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Gillian Cannon | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 4 years |
| Ann Li Lee | M | 63 | 6 years | |
| Andrew Fromkin | M | 58 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 years |
| Charlotte Merritt | F | 61 | 7 years | |
| Meg Elias | F | 58 | 5 years | |
| David Berk | M | 45 | 5 years | |
| Tom Harris | M | - | - | |
| Ilan Oren | M | 40 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Timothy Nelson | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Sakshi Chhabra | F | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Richard DeLuca | M | 61 | 13 years | |
| Denise Williams | F | - | 15 years | |
| Sef P. Kurstjens | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Kenneth Ludlum | M | 70 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Don Plummer | M | - | - | |
| Berndt A. E. Modig | M | 65 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Rakhi Kumar | F | 44 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 9 years |
| Pierre Legault | M | 63 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Sanat Chattopadhyay | M | - | 15 years | |
| Paul Davis | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jacqualyn Fouse | M | 62 | 7 years | |
| Robert Hugin | M | 69 | 19 years | |
| Fred Hassan | M | 78 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 6 years |
| Aditya Kohli | M | 36 | 2 years | |
| Todd Branning | M | 54 | 1 years | |
| Lynn Seely | M | 65 | 5 years | |
| Thomas Daniel | M | 69 | 10 years | |
| Scott Smith | M | 61 | 10 years | |
| Richard Clark | M | 77 | 6 years | |
| Peter Kellogg | M | 67 | 5 years | |
| Tadataka Yamada | M | 77 | 3 years | |
| Sven Håkan Björklund | M | 68 | 5 years | |
| Scott Burrows | M | 47 | 4 years | |
| Matthew Lang | M | 48 | - | |
| Joe Hand | M | - | 6 years | |
| Timothy J. Smith | M | - | - | |
| Jean-Marie Canan | M | 68 | 5 years | |
| Julia Haller | M | 69 | - | |
| Thomas Perone | M | 59 | 12 years | |
| Gerald F. Masoudi | M | 56 | 3 years | |
| Nancy Valente | M | 66 | 2 years | |
| Michael Nally | M | 48 | 10 years | |
| Andreas Eggert | M | 56 | 5 years | |
| Thomas Sabatino | M | 65 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 5 years |
| Keith L. Klein | M | 60 | 2 years | |
| Jens Jesper Ovesen | M | 67 | 3 years | |
| Perry Karsen | M | 69 | 3 years | |
| Melanie Lee | M | 65 | 3 years | |
| Kåre Schultz | M | 62 | 2 years | |
| Michael Bonney | M | 65 | 4 years | |
| William Rastetter | M | 76 | 6 years | |
| Steven Goldstone | M | 78 | 6 years | |
| Gilla Kaplan | M | 76 | 20 years | |
| Richard Morgan | M | 79 | 29 years | |
| John Weiland | M | 68 | 1 years | |
| Rodman L. Drake | M | 80 | 8 years | |
| Ulf Arne Wiinberg | M | 66 | 6 years | |
| Robert Hershberg | M | 61 | 5 years | |
| Corey Padovano | M | - | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 86 | 86.00% |
| United Kingdom | 10 | 10.00% |
| Denmark | 9 | 9.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Terrie Curran
- Personal Network
